Publisher: Wiley-Blackwell

Related content
Volume 24, Number 4, 1 July 2011

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Cutaneous and mucosal reactions to oncologic therapy
pp. 385-385(1)
Author: LACOUTURE, MARIO E.

Favourites:Add to Favourites

Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib
pp. 386-395(10)
Authors: AMITAY‐LAISH, IRIS; STEMMER, SALOMON M.; LACOUTURE, MARIO E.

Favourites:Add to Favourites

Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib
pp. 396-400(5)
Authors: MCLELLAN, BETH; KERR, HOLLY

Favourites:Add to Favourites

Dermatologic manifestations of cytotoxic therapy
pp. 401-410(10)
Authors: HUANG, VICTOR; ANADKAT, MILAN

Favourites:Add to Favourites

Acute graft‐versus‐host disease following hematopoietic stem‐cell transplantation
pp. 411-423(13)
Authors: HU, STEPHANIE W.; COTLIAR, JONATHAN

Favourites:Add to Favourites

Management of cancer therapy‐induced oral mucositis
pp. 424-431(8)
Authors: BARASCH, ANDREI; EPSTEIN, JOEL B.

Favourites:Add to Favourites

Treatment of chemotherapy‐induced alopecia
pp. 432-442(11)
Authors: YEAGER, CAROLINE E.; OLSEN, ELISE A.

Favourites:Add to Favourites

Colchicine in the management of mucous membrane pemphigoid
pp. 443-445(3)
Authors: CHAIDEMENOS, GEORGIOS; SIDIROPOULOS, THEODOROS; KATSIOULA, PARASKEVOULA; KOUSSIDOU‐EREMONDI, THALIA

Favourites:Add to Favourites

Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti‐TNF‐α treatment
pp. 446-451(6)
Authors: RENZO, LAURA DI; SARACENO, ROSITA; SCHIPANI, CATERINA; RIZZO, MARIAGIOVANNA; BIANCHI, ALESSIA; NOCE, ANNALISA; ESPOSITO, MARIA; TIBERTI, SERGIO; CHIMENTI, SERGIO; DE LORENZO, ANTONINO

Favourites:Add to Favourites

Subungual exostosis treated with an in situ thin split‐thickness toenail bed graft
pp. 452-454(3)
Authors: CHOI, CHANG‐MIN; CHO, HEE‐RYUNG; LEW, BARK‐LYNN; SIM, WOO‐YOUNG

Favourites:Add to Favourites

Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10‐year follow‐up
pp. 455-461(7)
Authors: ROSSI, A.; CANTISANI, C.; SCARNĂ², M.; TRUCCHIA, A.; FORTUNA, M. C.; CALVIERI, S.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more